Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vision loss
Biotech
Novo Holdings-backed Claris Bio emerges with $118M
A new biotech has come into view with a $118 million series B and a vision for making the front of the eye front-of-mind.
Darren Incorvaia
Jul 28, 2026 8:00am
J&J hands back failed gene therapy to MeiraGTx
Apr 16, 2026 10:17am
Ocugen’s CEO wants to bring gene therapy to the masses
Apr 16, 2026 9:00am
Fatty acid eye injections restore vision in old mice
Sep 26, 2025 2:10pm
Alcon sees Staar Surgical for $1.5B deal
Aug 5, 2025 11:00am
J&J launches daily contact lens for astigmatism, presbyopia
Jun 23, 2025 11:48am